Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Molecular mechanisms of Long-QT Syndrome Type-2 caused by cell surface destabilization of hERG

EF 2013-14

Résumé
Indiscriminate disposal of partially unfolded yet functional proteins by protein quality control (QC) systems contributes to the loss-of-function phenotype in various conformational diseases. To date, the endoplasmic reticulum (ER) QC machinery is well characterized; however, the machinery acting at peripheral cellular compartments, including the plasma membrane (PM) remain poorly understood. The human ether-a-go-go (hERG) gene encodes the Kv11.1 K+ channel involved in the repolarization of cardiac cells. Loss of hERG functional expression is associated with long QT syndrome type-2 (LQT2) which predisposes to fatal arrhythmia. A subset of LQT2 involves impaired processing of misfolded yet functional hERG at the ER. Recently, we found that misfolded hERG at the PM are ubiquitinated by the CHIP E3 ubiquitin ligase, resulting in increased turnover via lysosomal proteolysis and contributing to the LQT2 loss-of-expression phenotype. This machinery parallels that described by our lab to act on other misfolded PM proteins, including disease-associated variants of CFTR. To date, CHIP is the only E3 implicated in peripheral QC. However, complete CHIP knockdown produces only ~50% reversal of misfolded hERG PM-turnover and ubiquitination. Consequently, we hypothesize that other E3s contribute to hERG PM QC. This project aims to uncover the identity and mechanisms of additional E3 ligases that prematurely eliminate misfolded yet functional hERG from the PM. Candidates will be identified using novel partially-misfolded hERG substrates in conjunction with a phenotypic siRNA screen. The impact of candidate E3 overexpression or knockdown on the cellular processing (internalization, endocytic recycling, lysosomal delivery) and ubiquitination of misfolded hERG will be evaluated using microscopy, cell biology and biochemistry techniques. The molecular machinery involved in E3 ligase substrate recognition and binding will be identified using proteomics and systems biology approaches
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
307815
Name
Foo Brian
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular mechanisms of Long-QT Syndrome Type-2 caused by cell surface destabilization of hERG
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Herg K+ Channel; Inheritable Diseases; Long Qt Syndrome Type 2; Plasma Membrane; Protein Quality Control; Protein Trafficking; Protein Unfolding; Proteomics; Ubiquitination
Abstract
Indiscriminate disposal of partially unfolded yet functional proteins by protein quality control (QC) systems contributes to the loss-of-function phenotype in various conformational diseases. To date, the endoplasmic reticulum (ER) QC machinery is well characterized; however, the machinery acting at peripheral cellular compartments, including the plasma membrane (PM) remain poorly understood. The human ether-a-go-go (hERG) gene encodes the Kv11.1 K+ channel involved in the repolarization of cardiac cells. Loss of hERG functional expression is associated with long QT syndrome type-2 (LQT2) which predisposes to fatal arrhythmia. A subset of LQT2 involves impaired processing of misfolded yet functional hERG at the ER. Recently, we found that misfolded hERG at the PM are ubiquitinated by the CHIP E3 ubiquitin ligase, resulting in increased turnover via lysosomal proteolysis and contributing to the LQT2 loss-of-expression phenotype. This machinery parallels that described by our lab to act on other misfolded PM proteins, including disease-associated variants of CFTR. To date, CHIP is the only E3 implicated in peripheral QC. However, complete CHIP knockdown produces only ~50% reversal of misfolded hERG PM-turnover and ubiquitination. Consequently, we hypothesize that other E3s contribute to hERG PM QC. This project aims to uncover the identity and mechanisms of additional E3 ligases that prematurely eliminate misfolded yet functional hERG from the PM. Candidates will be identified using novel partially-misfolded hERG substrates in conjunction with a phenotypic siRNA screen. The impact of candidate E3 overexpression or knockdown on the cellular processing (internalization, endocytic recycling, lysosomal delivery) and ubiquitination of misfolded hERG will be evaluated using microscopy, cell biology and biochemistry techniques. The molecular machinery involved in E3 ligase substrate recognition and binding will be identified using proteomics and systems biology approaches
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Foo, Brian
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~